Utilisation patterns of immunomodulators and pregnancy outcomes in systemic lupus erythematosus: Insights from Korean national data

• Published in: Lupus Vol. 34; no. 2; pp. 140 - 148
• Main Authors: Jung, Yu-Seon, Song, Yeo-Jin, Lee, Hyeon Ji, Kim, Eunji, Cho, Soo-Kyung, Sung, Yoon-Kyoung, Jung, Sun-Young
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.02.2025; Sage Publications Ltd
• Subjects: Adult; Databases, Factual; Drug Utilization - trends; Female; Humans; Hydroxychloroquine; Hydroxychloroquine - therapeutic use; Immunologic Factors - therapeutic use; Immunomodulation; Immunomodulators; Immunosuppressive agents; Immunosuppressive Agents - therapeutic use; Lupus; Lupus Erythematosus, Systemic - drug therapy; Pregnancy; Pregnancy Complications - drug therapy; Pregnancy Outcome - epidemiology; Republic of Korea - epidemiology; Systemic lupus erythematosus; Trends; Young Adult; Republic of Korea; Pregnancy; immunosuppressive agents; systemic; hydroxychloroquine; lupus erythematosus; drug utilisation; aspirin
• ISSN: 0961-2033; 1477-0962; 1477-0962
• DOI: 10.1177/09612033241310087

Objectives To investigate the trends in immunomodulator use and pregnancy outcomes among pregnant women with systemic lupus erythematosus (SLE), a condition requiring medication to maintain disease activity. Methods This descriptive study used data from the National Health Information Database in Korea from 2002 to 2018. We included 5,044 pregnancies initiated between 2005 and 2017 in 3,120 SLE patients. Annual trends in SLE therapy, drug utilisation patterns during the preconception and pregnancy periods, and pregnancy outcomes were analysed. Results Pregnancy compatible immunosuppressant (PC-IS) and hydroxychloroquine use during the first trimester were 10.7% and 41.4%, respectively. Most SLE medications exhibited a decline in usage from the preconception period to the first trimester. A prescription rate of 0.9% for pregnancy incompatible immunosuppressants (PIC-IS) was observed during the first trimester, and the incidence of live births, stillbirths, and abortions remained consistent from 2005 to 2017. Conclusions Insufficient usage of hydroxychloroquine and PC-IS, along with a reduction in PIC-IS usage primarily during early pregnancy rather than before conception, highlights the unmet need for preconceptional family planning with appropriate medication management strategies in SLE pregnancies.